Recombinant multi-species DOPA decarboxylase/DDC protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DOPA decarboxylase/DDC protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The encoded protein catalyzes the decarboxylation of L-3,4-dihydroxyphenylalanine (DOPA) to dopamine, L-5-hydroxytryptophan to serotonin and L-tryptophan to tryptamine. Defects in this gene are the cause of aromatic L-amino-acid decarboxylase deficiency (AADCD). AADCD deficiency is an inborn error in neurotransmitter metabolism that leads to combined serotonin and catecholamine deficiency. Multiple alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jun 2011]
The Alternative Names of target: AADC,Aadc,Aromatic-L-amino-acid decarboxylase,DDC,DOPA decarboxylase,DOPA decarboxylase (DDC),Ddc

Target products collectionGo to DOPA decarboxylase/DDC products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T62193-Ag-1/ GM-Tg-hg-T62193-Ag-2 Human DOPA decarboxylase/DDC protein Human
GM-Tg-rg-T62193-Ag-1/ GM-Tg-rg-T62193-Ag-2 Rat DOPA decarboxylase/DDC protein Rat
GM-Tg-mg-T62193-Ag-1/ GM-Tg-mg-T62193-Ag-2 Mouse DOPA decarboxylase/DDC protein Mouse
GM-Tg-cynog-T62193-Ag-1/ GM-Tg-cynog-T62193-Ag-2 Cynomolgus/Rhesus macaque DOPA decarboxylase/DDC protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T62193-Ag-1/ GM-Tg-felg-T62193-Ag-2 Feline DOPA decarboxylase/DDC protein Feline
GM-Tg-cang-T62193-Ag-1/ GM-Tg-cang-T62193-Ag-2 Canine DOPA decarboxylase/DDC protein Canine
GM-Tg-bovg-T62193-Ag-1/ GM-Tg-bovg-T62193-Ag-2 Bovine DOPA decarboxylase/DDC protein Bovine
GM-Tg-equg-T62193-Ag-1/ GM-Tg-equg-T62193-Ag-2 Equine DOPA decarboxylase/DDC protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T62193-Ag-1/ GM-Tg-hg-T62193-Ag-2; GM-Tg-rg-T62193-Ag-1/ GM-Tg-rg-T62193-Ag-2;
GM-Tg-mg-T62193-Ag-1/ GM-Tg-mg-T62193-Ag-2; GM-Tg-cynog-T62193-Ag-1/ GM-Tg-cynog-T62193-Ag-2;
GM-Tg-felg-T62193-Ag-1/ GM-Tg-felg-T62193-Ag-2; GM-Tg-cang-T62193-Ag-1/ GM-Tg-cang-T62193-Ag-2;
GM-Tg-bovg-T62193-Ag-1/ GM-Tg-bovg-T62193-Ag-2; GM-Tg-equg-T62193-Ag-1/ GM-Tg-equg-T62193-Ag-2
Products Name DOPA decarboxylase/DDC protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name DOPA decarboxylase/DDC
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DOPA decarboxylase/DDC protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.